LRRC27
gene geneOn this page
Also known as KIAA1674
Summary
LRRC27 (leucine rich repeat containing 27, HGNC:29346) is a protein-coding gene on chromosome 10q26.3, encoding Leucine-rich repeat-containing protein 27 (Q9C0I9).
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 127 total
- MANE Select transcript:
NM_030626
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29346 |
| Approved symbol | LRRC27 |
| Name | leucine rich repeat containing 27 |
| Location | 10q26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1674 |
| Ensembl gene | ENSG00000148814 |
| Ensembl biotype | protein_coding |
| Entrez | 80313 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 9 protein_coding, 8 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000344079, ENST00000368612, ENST00000368613, ENST00000368614, ENST00000450442, ENST00000462656, ENST00000472387, ENST00000472556, ENST00000475747, ENST00000476889, ENST00000487000, ENST00000489204, ENST00000490055, ENST00000625755, ENST00000885091, ENST00000885092, ENST00000930529, ENST00000962088
RefSeq mRNA: 5 — MANE Select: NM_030626
NM_001143757, NM_001143758, NM_001143759, NM_001309474, NM_030626
CCDS: CCDS31316, CCDS44495, CCDS44496
Canonical transcript exons
ENST00000368614 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001833285 | 132332193 | 132332256 |
| ENSE00001904678 | 132375066 | 132381508 |
| ENSE00003503200 | 132365424 | 132365550 |
| ENSE00003514318 | 132333477 | 132333734 |
| ENSE00003535702 | 132347984 | 132348356 |
| ENSE00003544844 | 132344498 | 132344650 |
| ENSE00003576796 | 132361457 | 132361575 |
| ENSE00003592285 | 132355790 | 132355886 |
| ENSE00003631335 | 132351607 | 132351753 |
| ENSE00003670247 | 132342213 | 132342271 |
| ENSE00003686432 | 132337565 | 132337695 |
Expression profiles
Bgee: expression breadth ubiquitous, 201 present calls, max score 97.11.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.4658 / max 190.8089, expressed in 1683 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 107707 | 4.7278 | 1596 |
| 206063 | 0.3517 | 186 |
| 107709 | 0.1917 | 81 |
| 107710 | 0.0987 | 35 |
| 107708 | 0.0960 | 24 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 97.11 | gold quality |
| left testis | UBERON:0004533 | 96.82 | gold quality |
| right testis | UBERON:0004534 | 96.59 | gold quality |
| testis | UBERON:0000473 | 93.77 | gold quality |
| right uterine tube | UBERON:0001302 | 92.76 | gold quality |
| cortical plate | UBERON:0005343 | 90.14 | gold quality |
| ventricular zone | UBERON:0003053 | 88.49 | gold quality |
| adenohypophysis | UBERON:0002196 | 86.83 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.40 | gold quality |
| granulocyte | CL:0000094 | 86.30 | gold quality |
| right frontal lobe | UBERON:0002810 | 86.24 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 86.23 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 86.23 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.12 | gold quality |
| sural nerve | UBERON:0015488 | 85.64 | gold quality |
| prefrontal cortex | UBERON:0000451 | 85.40 | gold quality |
| hypothalamus | UBERON:0001898 | 84.61 | gold quality |
| nucleus accumbens | UBERON:0001882 | 84.60 | gold quality |
| amygdala | UBERON:0001876 | 84.49 | gold quality |
| pituitary gland | UBERON:0000007 | 84.43 | gold quality |
| caudate nucleus | UBERON:0001873 | 84.38 | gold quality |
| putamen | UBERON:0001874 | 83.53 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 83.35 | gold quality |
| spleen | UBERON:0002106 | 83.31 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 83.23 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 83.19 | gold quality |
| neocortex | UBERON:0001950 | 82.98 | gold quality |
| metanephros cortex | UBERON:0010533 | 82.97 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.87 | gold quality |
| thyroid gland | UBERON:0002046 | 82.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.61 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
188 targeting LRRC27, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4713-3P | 100.00 | 65.92 | 505 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
Literature-anchored findings (GeneRIF, showing 1)
- Exploring the Novel Susceptibility Gene Variants for Primary Open-Angle Glaucoma in East Asian Cohorts: The GLAU-GENDISK Study. (PMID:31937794)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lrrc27 | ENSMUSG00000015980 |
| rattus_norvegicus | Lrrc27 | ENSRNOG00000017538 |
Paralogs (31): LRRC7 (ENSG00000033122), PHLPP2 (ENSG00000040199), LRRC40 (ENSG00000066557), LRCH4 (ENSG00000077454), PHLPP1 (ENSG00000081913), SHOC2 (ENSG00000108061), ERBIN (ENSG00000112851), LRRC39 (ENSG00000122477), LRCH2 (ENSG00000130224), LRCH1 (ENSG00000136141), LRRC8A (ENSG00000136802), LRRC1 (ENSG00000137269), MFHAS1 (ENSG00000147324), LRRK1 (ENSG00000154237), LRRC58 (ENSG00000163428), LRRC2 (ENSG00000163827), LRRC18 (ENSG00000165383), LRRC28 (ENSG00000168904), LRRC8E (ENSG00000171017), LRRC8C (ENSG00000171488), LRRC8D (ENSG00000171492), PIDD1 (ENSG00000177595), SCRIB (ENSG00000180900), LRCH3 (ENSG00000186001), LRRIQ4 (ENSG00000188306), LRRC8B (ENSG00000197147), LRRC10 (ENSG00000198812), LRRC10B (ENSG00000204950), LRRC30 (ENSG00000206422), LRRC69 (ENSG00000214954), LRRD1 (ENSG00000240720)
Protein
Protein identifiers
Leucine-rich repeat-containing protein 27 — Q9C0I9 (reviewed: Q9C0I9)
All UniProt accessions (2): Q9C0I9, A0A140VJN2
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9C0I9-1 | 1 | yes |
| Q9C0I9-2 | 2 | |
| Q9C0I9-3 | 3 | |
| Q9C0I9-4 | 4 |
RefSeq proteins (5): NP_001137229, NP_001137230, NP_001137231, NP_001296403, NP_085129* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR003591 | Leu-rich_rpt_typical-subtyp | Repeat |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR050715 | LRR-SigEffector_domain | Family |
Pfam: PF13855
UniProt features (16 total): repeat 5, splice variant 4, sequence conflict 2, region of interest 2, chain 1, sequence variant 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9C0I9-F1 | 63.30 | 0.23 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 90 (showing top):
COATES_MACROPHAGE_M1_VS_M2_DN, LEIN_MEDULLA_MARKERS, MARSON_BOUND_BY_FOXP3_STIMULATED, GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CHEN_METABOLIC_SYNDROM_NETWORK, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, YANG_BCL3_TARGETS_UP, ALKBH3_TARGET_GENES, CBX5_TARGET_GENES, CEBPZ_TARGET_GENES, CREBL2_TARGET_GENES, FOXJ2_TARGET_GENES, FOXN3_TARGET_GENES, HES2_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
702 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRRC27 | C3orf22 | Q8N5N4 | 506 |
| LRRC27 | RNASE12 | Q5GAN4 | 447 |
| LRRC27 | ARHGAP22 | Q7Z5H3 | 447 |
| LRRC27 | C12orf56 | Q8IXR9 | 447 |
| LRRC27 | SMIM17 | P0DL12 | 437 |
| LRRC27 | JAKMIP3 | Q5VZ66 | 431 |
| LRRC27 | CCDC144A | A2RUR9 | 424 |
| LRRC27 | SH2D7 | A6NKC9 | 419 |
| LRRC27 | C1orf167 | Q5SNV9 | 418 |
| LRRC27 | CC2D2B | Q6DHV5 | 418 |
| LRRC27 | C22orf42 | Q6IC83 | 417 |
| LRRC27 | ANKRD62 | A6NC57 | 416 |
| LRRC27 | LRRC66 | Q68CR7 | 410 |
| LRRC27 | SPDYE4 | A6NLX3 | 399 |
| LRRC27 | CLPSL1 | A2RUU4 | 395 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LRRC27 | HMOX1 | psi-mi:“MI:0914”(association) | 0.530 |
| LRRC27 | H2AC4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| LRRC27 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| LRRC27 | SNRNP200 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (33): HMOX1 (Affinity Capture-MS), MCM8 (Affinity Capture-MS), SCRIB (Affinity Capture-MS), IFT52 (Affinity Capture-MS), LRRC40 (Affinity Capture-MS), POLA2 (Affinity Capture-MS), WDR19 (Affinity Capture-MS), BBS7 (Affinity Capture-MS), PJA1 (Affinity Capture-MS), LRRC27 (Affinity Capture-RNA), LRRC27 (Affinity Capture-MS), LRRC27 (Two-hybrid), LRRC27 (Proximity Label-MS), LRRC27 (Negative Genetic), LRRC27 (Affinity Capture-RNA)
ESM2 similar proteins: A5PKK7, A8E4X8, B1H222, Q13625, Q28C41, Q2HJA5, Q2KHX9, Q3B7M3, Q499E4, Q4KMA0, Q4V891, Q571B6, Q5M834, Q5RDH2, Q5T7V8, Q5U465, Q5XI03, Q5XIA0, Q5XJA2, Q5ZKM0, Q62036, Q6NRH3, Q6NVC9, Q6PCG6, Q6TYB5, Q7T320, Q7TNY7, Q7ZWE6, Q86XL3, Q8BRM2, Q8BVV7, Q8CG79, Q8IYY4, Q8K3I4, Q8N9B5, Q8NFW9, Q8TF30, Q8VCS6, Q91WZ8, Q96GE4
Diamond homologs: Q80YS5, Q9C0I9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
127 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 87 |
| Likely benign | 16 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2381 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:132333735:G:GG | donor_gain | 1.0000 |
| 10:132337558:A:AG | acceptor_gain | 1.0000 |
| 10:132337558:AT:A | acceptor_gain | 1.0000 |
| 10:132337558:ATG:A | acceptor_gain | 1.0000 |
| 10:132337559:T:G | acceptor_gain | 1.0000 |
| 10:132337559:T:TA | acceptor_gain | 1.0000 |
| 10:132344493:T:A | acceptor_gain | 1.0000 |
| 10:132344495:CAGG:C | acceptor_loss | 1.0000 |
| 10:132344496:A:AG | acceptor_gain | 1.0000 |
| 10:132344496:AG:A | acceptor_gain | 1.0000 |
| 10:132344497:G:GG | acceptor_gain | 1.0000 |
| 10:132344497:GG:G | acceptor_gain | 1.0000 |
| 10:132344497:GGGA:G | acceptor_gain | 1.0000 |
| 10:132344609:GGGC:G | donor_gain | 1.0000 |
| 10:132344648:AAG:A | donor_loss | 1.0000 |
| 10:132344650:GGTT:G | donor_loss | 1.0000 |
| 10:132344652:T:G | donor_loss | 1.0000 |
| 10:132344659:G:GT | donor_gain | 1.0000 |
| 10:132347982:AGAG:A | acceptor_gain | 1.0000 |
| 10:132347983:GAGG:G | acceptor_gain | 1.0000 |
| 10:132351605:A:AG | acceptor_gain | 1.0000 |
| 10:132351606:G:GG | acceptor_gain | 1.0000 |
| 10:132351750:GACG:G | donor_gain | 1.0000 |
| 10:132351754:G:GG | donor_gain | 1.0000 |
| 10:132351754:G:T | donor_loss | 1.0000 |
| 10:132351755:T:A | donor_loss | 1.0000 |
| 10:132365422:A:AG | acceptor_gain | 1.0000 |
| 10:132365423:G:GA | acceptor_gain | 1.0000 |
| 10:132365423:GT:G | acceptor_gain | 1.0000 |
| 10:132365423:GTGC:G | acceptor_gain | 1.0000 |
AlphaMissense
3449 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:132342257:T:C | L129S | 0.991 |
| 10:132342218:T:C | L116S | 0.987 |
| 10:132337569:T:C | L72S | 0.986 |
| 10:132342227:T:C | L119S | 0.984 |
| 10:132342243:T:A | N124K | 0.984 |
| 10:132342243:T:G | N124K | 0.984 |
| 10:132344548:T:C | F151L | 0.984 |
| 10:132344550:C:A | F151L | 0.984 |
| 10:132344550:C:G | F151L | 0.984 |
| 10:132337647:T:C | L98P | 0.982 |
| 10:132337657:T:A | N101K | 0.982 |
| 10:132337657:T:G | N101K | 0.982 |
| 10:132337662:T:C | I103T | 0.979 |
| 10:132337641:T:C | L96P | 0.978 |
| 10:132344596:T:C | F167L | 0.978 |
| 10:132344598:C:A | F167L | 0.978 |
| 10:132344598:C:G | F167L | 0.978 |
| 10:132348214:T:C | F262L | 0.978 |
| 10:132348216:T:A | F262L | 0.978 |
| 10:132348216:T:G | F262L | 0.978 |
| 10:132337575:T:C | L74P | 0.976 |
| 10:132344538:C:G | C147W | 0.976 |
| 10:132337647:T:A | L98H | 0.974 |
| 10:132342241:A:G | N124D | 0.973 |
| 10:132342233:T:C | L121S | 0.972 |
| 10:132337656:A:T | N101I | 0.971 |
| 10:132342241:A:T | N124Y | 0.969 |
| 10:132344536:T:C | C147R | 0.968 |
| 10:132337613:T:C | F87L | 0.965 |
| 10:132337615:T:A | F87L | 0.965 |
dbSNP variants (sampled 300 via entrez): RS1000012358 (10:132331176 G>A), RS1000022984 (10:132371343 C>T), RS1000045057 (10:132330810 TA>T,TAA), RS1000070798 (10:132375797 C>T), RS1000082783 (10:132336656 A>C), RS1000162533 (10:132351633 T>A), RS1000178512 (10:132366195 G>A), RS1000209432 (10:132365920 C>G,T), RS1000212496 (10:132359218 G>A,T), RS1000266597 (10:132336347 A>C), RS1000278242 (10:132351483 AGTC>A), RS1000294243 (10:132342441 C>T), RS1000364669 (10:132381434 C>T), RS1000371219 (10:132376917 G>A), RS1000434109 (10:132328069 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007326_31 | Number of sexual partners | 1.000000e-10 |
| GCST007335_20 | Age at first sexual intercourse | 1.000000e-08 |
| GCST010119_1 | Glaucoma (primary open-angle) | 1.000000e-07 |
| GCST011125_19 | Caffeine consumption from coffee | 7.000000e-09 |
| GCST90000047_214 | Age at first sexual intercourse | 1.000000e-15 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009749 | age at first sexual intercourse measurement |
| EFO:0006781 | coffee consumption measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, increases methylation | 2 |
| Aflatoxin B1 | increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| naringenin | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| sodium arsenite | decreases expression | 1 |
| hydroquinone | decreases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| jinfukang | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Estradiol | affects expression | 1 |
| Lead | affects splicing | 1 |
| Pesticides | affects methylation | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| tert-Butylhydroperoxide | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.